Research progress on clinical application of liquid phase chip multiple detection technology
Liquid phase chip multiple detection technology is a multiple detection technique that utilizes classified coding microspheres suspended in liquid phase as reaction and signal detection carriers.It fully leverages the well-established flow cytometry detection principle to perform high-throughput analysis on most clinical biomolecules,such as nucleic acids and proteins.This technology has been widely applied in medical testing research.This article summarizes the clinical testing applications of liquid phase chip multiple detection technology in various systems,including respiratory,digestive,reproductive,nervous,endocrine,urinary,and musculoskeletal systems,for nucleic acid and protein detection.It has been found to have high performance and promising application prospects.Compared with traditional methods like ELISA and PCR,liquid phase chip multiple detection technology offers advantages such as a wide linear range,high throughput,fast detection speed,high sensitivity,strong specificity,and high accuracy,indicating its suitability for screening clinical disease indicators.
Liquid phase chip multiple detection technologyNucleic acidProteinClinical test